Figure 1From: 5thInternational AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice – Clinical sciencesProbability HIV positive or death by week 28 visit in infants uninfected at birth. Source: Chasela C, et al: Both maternal HAART and daily infant nevirapine (NVP) are effective in reducing HIV-1 transmission during breastfeeding in a randomized trial in Malawi: 28 week results of the Breastfeeding, Antiretroviral and Nutrition (BAN) Study. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention: Cape Town, South Africa. WELBC103 [6].Back to article page